DENVER INVESTMENT ADVISORS LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 95 filers reported holding CTI BIOPHARMA CORP in Q2 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
DENVER INVESTMENT ADVISORS LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2015$114,000
-25.0%
62,988
-2.1%
0.00%
-20.0%
Q4 2014$152,000
-1.9%
64,321
+0.4%
0.01%0.0%
Q3 2014$155,000
-8.8%
64,054
+6.0%
0.01%0.0%
Q2 2014$170,000–60,437–0.01%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q2 2015.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders